Status:

UNKNOWN

Vasopressor Infusion in Cesarean Delivery

Lead Sponsor:

Cairo University

Conditions:

Cesarean Section Complications

Spinal Anesthesia

Eligibility:

FEMALE

18-40 years

Phase:

PHASE4

Brief Summary

Comparison will be conducted between continuous variable infusions of both drugs (Phenylephrine and Norepinephrine) with starting doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylax...

Detailed Description

Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Many vasopressors have been used for prevention of post-spinal hypotension (PSH) during CD; however, t...

Eligibility Criteria

Inclusion

  • full term
  • pregnant women
  • scheduled for cesarean section

Exclusion

  • pre-ecpamsia
  • eclampsia
  • bleeding
  • cardiac dysfuction

Key Trial Info

Start Date :

August 20 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 10 2022

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03248791

Start Date

August 20 2017

End Date

March 10 2022

Last Update

September 27 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cairo University

Cairo, Egypt

Vasopressor Infusion in Cesarean Delivery | DecenTrialz